CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ – VBI Vaccines Inc. (“VBI” or the “Company”) today announced, that, in connection with its creditor protection proceedings under the Companies’ Creditors Arrangement Act (Canada) (the “CCAA”) and its previously announced sale and investment…